pediatr
patient
admit
hospit
acut
respiratori
infect
examin
presenc
respiratori
virus
either
direct
fluoresc
stain
use
monoclon
antibodi
rtpcr
three
consecut
winterspr
season
whole
patient
detect
posit
one
respiratori
virus
wide
circul
viru
human
respiratori
syncyti
viru
hrsv
infect
posit
patient
follow
human
metapneumoviru
hmpv
found
patient
influenza
viru
type
human
parainfluenzavirus
coinfect
signific
variat
circul
rate
hrsv
hmpv
influenzaviru
type
observ
individu
season
addit
circul
rate
differ
type
hmpv
chang
yearli
hmpv
circul
signific
lower
proport
hrsv
circul
rate
two
virus
closer
conclus
hmpv
subtyp
circul
yearli
northern
itali
flank
hrsv
major
respiratori
pathogen
infantil
patient
popul
human
metapneumoviru
hmpv
recent
identifi
human
respiratori
viral
pathogen
along
new
human
coronavirus
hcov
sarscov
new
viru
etiolog
agent
upper
lower
respiratori
tract
infect
immunocompet
immunocompromis
host
particular
infant
g
gerna
et
al
young
children
among
patient
sever
affect
hmpv
infect
howev
sever
epidemiolog
featur
hmpv
infect
remain
investig
particular
differ
circul
rate
hmpv
strain
well
differ
hmpv
type
subtyp
differ
season
rel
pathogen
hmpv
respect
human
respiratori
synctial
viru
hrsv
remain
defin
studi
examin
circul
rate
hmpv
among
respiratori
virus
consecut
winterspr
season
ii
rel
circul
type
subtyp
hmpv
period
iii
rel
impact
hmpv
compar
hrsv
determin
admiss
hospit
infant
acut
respiratori
infect
decemb
novemb
infant
young
children
admit
hospit
acut
respiratori
viru
infect
patient
fever
cough
lower
respiratori
tract
involv
nasopharyng
aspir
npa
collect
upon
admiss
divid
aliquot
one
use
molecular
assay
rtpcr
second
direct
fluoresc
antibodi
dfa
stain
respiratori
cell
third
shortterm
longterm
viru
isol
cell
cultur
fourth
frozen
backup
sampl
specimen
examin
influenzavirus
b
parainfluenzavirus
hpiv
hrsv
human
adenovirus
hadv
dfa
viru
isol
cell
cultur
addit
hcov
group
ii
hmpv
type
b
sought
rtpcr
type
hmpv
strain
achiev
sequenc
phylogenet
analysi
similarli
group
hcov
achiev
sequenc
studi
approv
ircc
policlinico
san
matteo
ethic
committe
simultan
detect
respiratori
virus
npa
refer
coinfect
rapid
viru
recoveri
achiev
cell
cultur
inocul
npa
sampl
onto
shell
vial
mixtur
cell
shell
vial
mdck
cell
stain
mab
requir
day
pi
convent
viru
recoveri
obtain
follow
inocul
tube
mdck
cell
stain
mab
day
pi
requir
follow
week
pool
fluoresceinlabel
mab
convent
respiratori
virus
influenzaviru
b
hpiv
hrsv
hadv
well
singl
fluoresceinconjug
mab
includ
pool
purchas
chemicon
intern
inc
temecula
ca
use
dfa
viru
identif
cell
cultur
follow
rt
reaction
pcr
assay
identif
hcov
hmpv
strain
optimis
detect
least
input
plasmid
copi
purpos
primer
hcov
group
ii
select
publish
protocol
wherea
primer
hmpv
type
b
gene
n
f
origin
design
genbank
publish
viru
sequenc
tabl
amplif
product
clone
plasmid
vector
ta
clone
kit
invitrogen
carlsbad
ca
quantit
standard
obtain
follow
titrat
insertcontain
plasmid
thu
defin
amount
target
sequenc
could
amplifi
parallel
clinic
sampl
nucleic
acid
extract
use
nuclisen
iso
kit
biomerieux
lyon
franc
rt
pcr
reaction
perform
report
pcr
product
examin
agaros
gel
classif
hmpv
strain
studi
type
b
subtyp
achiev
phylogenet
analysi
fragment
gene
f
n
hmpv
strain
respect
viral
sequenc
amplifi
gene
f
nt
gene
n
nt
fragment
hmpv
isol
well
refer
strain
align
clustal
w
program
version
wherea
sequenc
similar
comparison
carri
megalign
program
dnastar
inc
madison
wi
philip
njplot
program
use
construct
phylogenet
tree
nucleotid
sequenc
mean
neighbourjoin
method
distanc
matric
bootstrap
support
determin
resampl
sequenc
statist
differ
circul
rate
respiratori
viru
infect
among
consecut
season
determin
chi
squar
test
rel
distribut
differ
respiratori
virus
caus
sever
infect
requir
admiss
hospit
infant
young
children
three
consecut
winterspr
season
report
tabl
within
aliquot
patient
found
posit
respiratori
viru
differ
circul
rate
observ
respiratori
viru
infect
caus
influenzaviru
b
hpiv
hadv
hcov
coinfect
along
three
year
studi
contrari
signific
differ
circul
rate
tabl
found
influenzaviru
hrsv
hmpv
tabl
howev
hrsv
hmpv
infect
predomin
first
month
age
infect
evenli
distribut
first
year
age
tabl
surprisingli
group
coinfect
simultan
infect
patient
hmpv
hrsv
observ
singl
case
tabl
circul
rate
hmpv
reach
peak
fig
due
high
similar
patholog
caus
newborn
infant
circul
rate
hmpv
hrsv
analys
compar
relev
number
infect
patient
admit
hospit
winterspr
decemb
may
summerfal
june
novemb
season
year
virus
nearli
absent
summerfal
season
wherea
highli
circul
differ
proport
winterspr
season
although
incid
hrsv
infect
pediatr
patient
admit
epidemiolog
survey
circul
rate
import
respiratori
virus
respons
admiss
hospit
infant
young
children
defin
geograph
area
period
conduct
use
npa
sampl
clinic
specimen
order
contain
cost
basi
recent
acquir
result
show
compar
sensit
molecular
rtpcr
immunolog
monoclon
diagnost
approach
influenzavirus
b
hpiv
hrsv
hadv
detect
monoclon
antibodi
hcov
hmpv
detect
rtpcr
signific
differ
observ
circul
rate
major
respiratori
virus
signific
differ
circul
influenzaviru
hrsv
hmpv
found
consecut
winterspr
season
apart
influenzavirus
known
circul
differ
differ
year
hmpv
hrsv
circul
stabl
rate
first
season
examin
contrari
rel
proport
patient
infect
hrsv
decreas
sharpli
recent
season
patient
infect
hmpv
increas
significantli
consequ
number
young
patient
admit
hospit
lower
respiratori
tract
infect
caus
hmpv
increas
accordingli
yearli
variat
circul
rate
hmpv
recent
report
besid
strike
variat
overal
circul
rate
hmpv
signific
variat
circul
hmpv
subtyp
observ
studi
period
whether
differ
hmpv
type
subtyp
may
differenti
basi
nucleotid
sequenc
phylogenet
analysi
may
repres
true
serotyp
subserotyp
remain
determin
fact
ferret
immun
sera
report
identifi
two
distinct
serotyp
b
show
dilut
differ
homolog
heterolog
neutral
antibodi
titer
sever
primat
well
hamster
immun
sera
show
discrimin
capac
similarli
experi
alreadi
report
other
guinea
pig
immun
sera
abl
identifi
two
distinct
serotyp
thu
moment
term
type
subtyp
indic
genotyp
subgenotyp
rather
serotyp
subserotyp
recent
studi
group
use
fragment
gene
n
nt
possibl
identifi
amino
acid
substitut
posit
might
use
differenti
type
type
b
strain
monoclon
antibodi
reactiv
epitop
contain
differenti
amino
acid
might
discrimin
two
hmpv
type
simultan
circul
hrsv
hmpv
period
year
winterspr
season
patient
popul
infant
young
children
along
compar
degre
pathogen
could
hypothet
facilit
coinfect
two
member
paramyxovirina
subfamili
recent
populationbas
prospect
multicent
studi
children
requir
intens
care
conduct
germani
year
hmpv
infect
children
infect
hmpv
combin
hrsv
wherea
hmpv
detect
larg
seri
hrsvposit
children
requir
intens
care
support
data
support
hypothesi
coinfect
hrsv
hmpv
sever
infect
either
hrsv
hmpv
alon
least
children
less
year
age
studi
outsid
intens
care
unit
surprisingli
singl
case
coinfect
hmpv
hrsv
found
thu
suggest
coinfect
infrequ
immunocompet
host
refer
italian
pediatr
popul
admit
hospit
winterspr
season
follow
conclus
drawn
epidemiolog
studi
hmpv
strain
circul
differ
rate
differ
year
ii
chang
preval
hmpv
type
subtyp
occur
yearli
iii
preval
hmpv
versu
hrsv
infect
may
also
chang
significantli
differ
year
